About Us
What We Do
History
Our Management
Science
ASODE™
C-Duplex™
Pipeline
Pipeline
ASO
Fixed-Dose
Combination
News
Announcement
News
Notice
Contact
Contact Us
Address
Careers
KOR
ENG
News
News
News
No.
Title
Date
18
Autotelic Bio Selected for 2025 Deep Tech Challenge Project, Securing Up to KRW 10 Billion in Funding
2026-02-05
17
Autotelic Bio Selected for KDDF Project to Advance Antisense RNA Therapeutics
2026-02-05
16
Autotelic Bio Enters License and Technology Transfer Agreement with Aché for ATB-101
2026-02-05
15
Autotelic Bio Secures Phase 1 IND Approval for ATB-320 in Australia and Advances KOSDAQ Listing Plans
2026-02-05
14
Autotelic Bio and Chinoin Announce Exclusive License and Supply Agreement for ATB-101 in Mexico
2024-06-07
13
Autotelic Bio Appoints Hyungbae Kwon as CFO
2023-12-04
12
Autotelic Bio, Dream CIS and Tigermed Signed an MOU for Mutual Cooperation for Global New Drug Development and Strategic Investment
2023-06-08
11
Autotelic Bio and Yungjin Pharm. Entered Co-Development and Technical Implementation of Hypertension and Diabetic Combination Drug
2023-03-14
10
Autotelic Bio's ATB-610, a Selective ALK5 Inhibitor with Inhalation Therapy for IPF Treatment, was Selected as a Research Project by KDDF
2022-11-25
9
Autotelic Bio to Initiate Phase 3 Clinical Trial for ATB-101, the World's 1st FDC for Hypertension and Diabetes
2022-07-04
1
2
